Crohn-betegség: vizsgálatok itt: Mexikó

In Mexikó 6 Also abroad 422

6 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Where
Benito Juarez Ciudad de Mexico, Chihuahua City, Cuernavaca, León, Mérida, Mexico City, Monterrey, Oaxaca City, San Pedro Garza García, Tlajomulco de Zúñiga
Életkor
16 év to 80 év
People
1200 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06430801 · EU 2023-508636-61-00
3. fázisTaking people
A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
Where
Mexico City, Veracruz
Életkor
2 év to 17 év
People
100 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07298421 · EU 2025-523318-96-00
2. fázisTaking people
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Where
Durango, Irapuato, Jalisco, Mérida, Mexico City, Distrito Federal, Morelia, Oaxaca City, Querétaro
Életkor
18 év to 85 év
People
385 worldwide
Run by
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
See details and how to joinNCT06226883 · EU 2023-508158-24-00
3. fázisTaking people
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Where
Aguascalientes, Chihuahua City, Ciudad Madero, Durango, Guadajalara, Guadalajara, Juriquilla, Mérida, Mexico City, Monterrey, Morelia, Puebla City, Tlalnepantla, Veracruz
Életkor
18 év to 70 év
People
290 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00
3. fázisTaking people
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Where
Jalisco, Monterrey, Veracruz
Életkor
16 év to 80 év
People
980 worldwide
Run by
Sanofi
See details and how to joinNCT07184931
3. fázisTaking people
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Where
Guadalajara, Mérida, Mexico
Életkor
16 év to 80 év
People
600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06819878 · EU 2024-513053-69-00